印度乳腺癌患者护理途径与延迟获得医疗服务的混合方法研究

Q2 Medicine
Radhika Kuthari, Raman Damor, Kalpita Shringarpure
{"title":"印度乳腺癌患者护理途径与延迟获得医疗服务的混合方法研究","authors":"Radhika Kuthari, Raman Damor, Kalpita Shringarpure","doi":"10.31557/APJCP.2025.26.6.2097","DOIUrl":null,"url":null,"abstract":"<p><p>Delay in receiving treatment or untimely discontinuation can impact patient survival. This study addresses the literature gap in knowledge about care pathway of patients following initiation of treatment, quantifies the delays in obtaining healthcare services and explores the challenges faced by them in this process.</p><p><strong>Methods: </strong>A concurrent triangulation mixed method study was conducted. All breast cancer patients above 18 years, who were aware of their diagnosis and whose treatment had commenced were included with their consent. The final sample size was 150. Patient pathway was documented through in-depth interviews and delay in access, diagnosis, and various treatment modalities was quantified after reviewing patient records. Factors associated with overall delay (from onset of symptoms to initiation of treatment) were identified by bivariate analysis. Inductive thematic analysis of interviews was done to identify reasons for delay.</p><p><strong>Results: </strong>Of 150 patients, 111 (74%) consulted at least two healthcare facilities and 75 (50%) consulted only government facilities during their treatment.  Majority, 124 (82.6%) patients faced delay in their care pathway; 88 (58.6%) experienced overall delay (median duration 109 days) which was significantly associated with patient's education and caregiver's occupation (p<0.05), and 48 (32%) out of 149 women were delayed in initiation of chemotherapy. Median access, diagnostic and treatment interval were 60 days, 20 days, and 6 days respectively. Median duration between surgery and chemotherapy, and surgery and radiotherapy was 10 days and 139 days respectively. The major themes that emerged in access delay were neglect, avoidance, and reliance on family. Diagnostic delay included themes of misdiagnosis and difficulty in navigating healthcare systems. Treatment delay included themes of misconceptions, avoidance, neglect, and affordability and accessibility of services.</p><p><strong>Conclusion: </strong>Majority of the patients visited at least two facilities and experienced delay in receiving healthcare services. Both patient and provider side challenges were responsible for delay.</p>","PeriodicalId":55451,"journal":{"name":"Asian Pacific Journal of Cancer Prevention","volume":"26 6","pages":"2097-2107"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Mixed Methods Study of Care Pathway and Delay in Obtaining Health Services by Breast Cancer Patients in India.\",\"authors\":\"Radhika Kuthari, Raman Damor, Kalpita Shringarpure\",\"doi\":\"10.31557/APJCP.2025.26.6.2097\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Delay in receiving treatment or untimely discontinuation can impact patient survival. This study addresses the literature gap in knowledge about care pathway of patients following initiation of treatment, quantifies the delays in obtaining healthcare services and explores the challenges faced by them in this process.</p><p><strong>Methods: </strong>A concurrent triangulation mixed method study was conducted. All breast cancer patients above 18 years, who were aware of their diagnosis and whose treatment had commenced were included with their consent. The final sample size was 150. Patient pathway was documented through in-depth interviews and delay in access, diagnosis, and various treatment modalities was quantified after reviewing patient records. Factors associated with overall delay (from onset of symptoms to initiation of treatment) were identified by bivariate analysis. Inductive thematic analysis of interviews was done to identify reasons for delay.</p><p><strong>Results: </strong>Of 150 patients, 111 (74%) consulted at least two healthcare facilities and 75 (50%) consulted only government facilities during their treatment.  Majority, 124 (82.6%) patients faced delay in their care pathway; 88 (58.6%) experienced overall delay (median duration 109 days) which was significantly associated with patient's education and caregiver's occupation (p<0.05), and 48 (32%) out of 149 women were delayed in initiation of chemotherapy. Median access, diagnostic and treatment interval were 60 days, 20 days, and 6 days respectively. Median duration between surgery and chemotherapy, and surgery and radiotherapy was 10 days and 139 days respectively. The major themes that emerged in access delay were neglect, avoidance, and reliance on family. Diagnostic delay included themes of misdiagnosis and difficulty in navigating healthcare systems. Treatment delay included themes of misconceptions, avoidance, neglect, and affordability and accessibility of services.</p><p><strong>Conclusion: </strong>Majority of the patients visited at least two facilities and experienced delay in receiving healthcare services. Both patient and provider side challenges were responsible for delay.</p>\",\"PeriodicalId\":55451,\"journal\":{\"name\":\"Asian Pacific Journal of Cancer Prevention\",\"volume\":\"26 6\",\"pages\":\"2097-2107\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Asian Pacific Journal of Cancer Prevention\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31557/APJCP.2025.26.6.2097\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Pacific Journal of Cancer Prevention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31557/APJCP.2025.26.6.2097","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

延迟接受治疗或过早停止治疗会影响患者的生存。本研究解决了文献中关于患者开始治疗后的护理途径的知识缺口,量化了获得医疗服务的延迟,并探讨了他们在这一过程中面临的挑战。方法:采用并行三角测量混合方法进行研究。所有18岁以上、知道自己的诊断并已开始治疗的乳腺癌患者均在其同意的情况下被纳入研究。最终样本量为150人。通过深入访谈记录了患者的路径,并在审查患者记录后对获取、诊断和各种治疗方式进行了量化。通过双变量分析确定与总体延迟(从症状出现到开始治疗)相关的因素。对访谈进行了归纳专题分析,以确定延迟的原因。结果:在150名患者中,111名(74%)在治疗期间至少咨询了两家医疗机构,75名(50%)仅咨询了政府机构。124例(82.6%)患者面临护理路径延迟;88例(58.6%)出现总体延迟(中位持续时间109天),这与患者的教育程度和护理人员的职业显著相关(结论:大多数患者至少访问了两个设施,并且在接受医疗保健服务方面出现延迟。患者和提供者方面的挑战都是造成延误的原因。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Mixed Methods Study of Care Pathway and Delay in Obtaining Health Services by Breast Cancer Patients in India.

Delay in receiving treatment or untimely discontinuation can impact patient survival. This study addresses the literature gap in knowledge about care pathway of patients following initiation of treatment, quantifies the delays in obtaining healthcare services and explores the challenges faced by them in this process.

Methods: A concurrent triangulation mixed method study was conducted. All breast cancer patients above 18 years, who were aware of their diagnosis and whose treatment had commenced were included with their consent. The final sample size was 150. Patient pathway was documented through in-depth interviews and delay in access, diagnosis, and various treatment modalities was quantified after reviewing patient records. Factors associated with overall delay (from onset of symptoms to initiation of treatment) were identified by bivariate analysis. Inductive thematic analysis of interviews was done to identify reasons for delay.

Results: Of 150 patients, 111 (74%) consulted at least two healthcare facilities and 75 (50%) consulted only government facilities during their treatment.  Majority, 124 (82.6%) patients faced delay in their care pathway; 88 (58.6%) experienced overall delay (median duration 109 days) which was significantly associated with patient's education and caregiver's occupation (p<0.05), and 48 (32%) out of 149 women were delayed in initiation of chemotherapy. Median access, diagnostic and treatment interval were 60 days, 20 days, and 6 days respectively. Median duration between surgery and chemotherapy, and surgery and radiotherapy was 10 days and 139 days respectively. The major themes that emerged in access delay were neglect, avoidance, and reliance on family. Diagnostic delay included themes of misdiagnosis and difficulty in navigating healthcare systems. Treatment delay included themes of misconceptions, avoidance, neglect, and affordability and accessibility of services.

Conclusion: Majority of the patients visited at least two facilities and experienced delay in receiving healthcare services. Both patient and provider side challenges were responsible for delay.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.80
自引率
0.00%
发文量
779
审稿时长
3 months
期刊介绍: Cancer is a very complex disease. While many aspects of carcinoge-nesis and oncogenesis are known, cancer control and prevention at the community level is however still in its infancy. Much more work needs to be done and many more steps need to be taken before effective strategies are developed. The multidisciplinary approaches and efforts to understand and control cancer in an effective and efficient manner, require highly trained scientists in all branches of the cancer sciences, from cellular and molecular aspects to patient care and palliation. The Asia Pacific Organization for Cancer Prevention (APOCP) and its official publication, the Asia Pacific Journal of Cancer Prevention (APJCP), have served the community of cancer scientists very well and intends to continue to serve in this capacity to the best of its abilities. One of the objectives of the APOCP is to provide all relevant and current scientific information on the whole spectrum of cancer sciences. They aim to do this by providing a forum for communication and propagation of original and innovative research findings that have relevance to understanding the etiology, progression, treatment, and survival of patients, through their journal. The APJCP with its distinguished, diverse, and Asia-wide team of editors, reviewers, and readers, ensure the highest standards of research communication within the cancer sciences community across Asia as well as globally. The APJCP publishes original research results under the following categories: -Epidemiology, detection and screening. -Cellular research and bio-markers. -Identification of bio-targets and agents with novel mechanisms of action. -Optimal clinical use of existing anti-cancer agents, including combination therapies. -Radiation and surgery. -Palliative care. -Patient adherence, quality of life, satisfaction. -Health economic evaluations.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信